The global Implantable Neurostimulation Devices market size is expected to reach US$ 14080 million by 2029, growing at a CAGR of 11.2% from 2023 to 2029.

Implantable Neurostimulation Devices - Market

Neurostimulation is a therapeutic activation of part of the nervous system using microelectrodes. The electrodes are used to interface with excitable tissue in order to either restore sensation, such as a cochlear implant for hearing, or control anorgan, such as a heart pacemaker.

Neurostimulation technology improves the life quality of those who are severely paralyzed or suffering from profound losses to various sense organs. It serves as the key part of neural prosthetics for hearing aids, artificial vision, artificial limbs, and brain-machine interfaces. In the case of neural stimulation, mostly an electrical stimulation is utilized and charge-balanced biphasic constant current waveforms of capacitive coupled charge injection approaches are adopted. Alternatively, the transcranial magnetic stimulation has been proposed as a non-invasive method in which a magnetic field causes neurostimulation.

Neurostimulation devices are implantable devices that help in the therapeutic activation of the nervous systems. These devices deliver electrical stimulation to the brain and nervous systems for the treatment of various types of neurological disorders such as pain, epilepsy, Parkinson's disease, depression, obsessive-compulsive disorder, dystonia, and tremors. These devices target specific areas of the brain or spinal cord by blocking the pain messages before they reach the brain.

The market is mainly driven by the significant applications of Implantable Neurostimulation Devices in various end use industries. The expanding demands from the Pain Management, Parkinson's Disease, Urinary and Fecal Incontinence and Epilepsy, are propelling Implantable Neurostimulation Devices market. Spinal Cord Stimulation (SCS), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Gastric Electric Stimulation (GES) segment is estimated at % CAGR for the next seven-year period.

Global Implantable Neurostimulation Devices key players include Medtronic, Boston Scientific, St. Jude Medical (Abbott), etc. Global top three manufacturers hold a share over 75%.

North America is the largest market, with a share over 80%, followed by Europe, and Asia (Ex.China), both have a share about 10 percent.

In terms of product, Spinal Cord Stimulation (SCS) is the largest segment, with a share over 55%. And in terms of application, the largest application is Pain Management, followed by Parkinson’s Disease, Epilepsy, Urinary and Fecal Incontinence, etc.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Implantable Neurostimulation Devices, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Implantable Neurostimulation Devices market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Implantable Neurostimulation Devices market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Implantable Neurostimulation Devices sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Implantable Neurostimulation Devices covered in this report include Medtronic, Boston Scientific, St. Jude Medical (Abbott), LivaNova, Nevro, NeuroPace, Beijing Pins and Synapse Biomedical, etc.

The global Implantable Neurostimulation Devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

Medtronic

Boston Scientific

St. Jude Medical (Abbott)

LivaNova

Nevro

NeuroPace

Beijing Pins

Synapse Biomedical

Scope of Implantable Neurostimulation Devices - Market Report

Report Metric	Details
Report Name	Implantable Neurostimulation Devices - Market
Forecasted market size in 2029	US$ 14080 million
CAGR	11.2%
Forecasted years	2023 - 2029
Global Implantable Neurostimulation Devices market, by region:	North America (U.S., Canada, Mexico) Europe (Germany, France, UK, Italy, etc.) Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.) South America (Brazil, etc.) Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Implantable Neurostimulation Devices market, Segment by Type:	Spinal Cord Stimulation (SCS) Gastric Electric Stimulation (GES) Deep Brain Stimulation (DBS) Sacral Nerve Stimulation (SNS) Vagus Nerve Stimulation (VNS) Others
Global Implantable Neurostimulation Devices market, by Application	Pain Management Parkinson's Disease Urinary and Fecal Incontinence Epilepsy Gastroparesis Others
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Implantable Neurostimulation Devices manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Implantable Neurostimulation Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.

FAQ for this report

What is the Implantable Neurostimulation Devices - Market size in 2029?

Ans: The Implantable Neurostimulation Devices - Market size in 2029 will be US$ 14080 million.

What is the market share of major companies in Implantable Neurostimulation Devices - Market?

Ans: Global top three manufacturers hold a share over 75%.

What is the Implantable Neurostimulation Devices - Market share by type?

Ans: In terms of product, Spinal Cord Stimulation (SCS) is the largest segment, with a share over 55%.

What are the Application segmentation covered in the Implantable Neurostimulation Devices - Market report?

Ans: The Applications covered in the Implantable Neurostimulation Devices - Market report are Pain Management, Parkinson's Disease, Urinary and Fecal Incontinence, Epilepsy, Gastroparesis, Others

What are the Type segmentation covered in the Implantable Neurostimulation Devices - Market report?

Ans: The Types covered in the Implantable Neurostimulation Devices - Market report are Spinal Cord Stimulation (SCS), Gastric Electric Stimulation (GES), Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS), Vagus Nerve Stimulation (VNS), Others

1 Implantable Neurostimulation Devices Market Overview

1.1 Implantable Neurostimulation Devices Product Overview

1.2 Implantable Neurostimulation Devices Market Segment by Type

1.2.1 Spinal Cord Stimulation (SCS)

1.2.2 Gastric Electric Stimulation (GES)

1.2.3 Deep Brain Stimulation (DBS)

1.2.4 Sacral Nerve Stimulation (SNS)

1.2.5 Vagus Nerve Stimulation (VNS)

1.2.6 Others

1.3 Global Implantable Neurostimulation Devices Market Size by Type

1.3.1 Global Implantable Neurostimulation Devices Market Size Overview by Type (2018-2029)

1.3.2 Global Implantable Neurostimulation Devices Historic Market Size Review by Type (2018-2023)

1.3.3 Global Implantable Neurostimulation Devices Forecasted Market Size by Type (2024-2029)

1.4 Key Regions Market Size Segment by Type

1.4.1 North America Implantable Neurostimulation Devices Sales Breakdown by Type (2018-2023)

1.4.2 Europe Implantable Neurostimulation Devices Sales Breakdown by Type (2018-2023)

1.4.3 Asia-Pacific Implantable Neurostimulation Devices Sales Breakdown by Type (2018-2023)

1.4.4 Latin America Implantable Neurostimulation Devices Sales Breakdown by Type (2018-2023)

1.4.5 Middle East and Africa Implantable Neurostimulation Devices Sales Breakdown by Type (2018-2023)

2 Global Implantable Neurostimulation Devices Market Competition by Company

2.1 Global Top Players by Implantable Neurostimulation Devices Sales (2018-2023)

2.2 Global Top Players by Implantable Neurostimulation Devices Revenue (2018-2023)

2.3 Global Top Players by Implantable Neurostimulation Devices Price (2018-2023)

2.4 Global Top Manufacturers Implantable Neurostimulation Devices Manufacturing Base Distribution, Sales Area, Product Type

2.5 Implantable Neurostimulation Devices Market Competitive Situation and Trends

2.5.1 Implantable Neurostimulation Devices Market Concentration Rate (2018-2023)

2.5.2 Global 5 and 10 Largest Manufacturers by Implantable Neurostimulation Devices Sales and Revenue in 2022

2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Implantable Neurostimulation Devices as of 2022)

2.7 Date of Key Manufacturers Enter into Implantable Neurostimulation Devices Market

2.8 Key Manufacturers Implantable Neurostimulation Devices Product Offered

2.9 Mergers & Acquisitions, Expansion

3 Implantable Neurostimulation Devices Status and Outlook by Region

3.1 Global Implantable Neurostimulation Devices Market Size and CAGR by Region: 2018 VS 2022 VS 2029

3.2 Global Implantable Neurostimulation Devices Historic Market Size by Region

3.2.1 Global Implantable Neurostimulation Devices Sales in Volume by Region (2018-2023)

3.2.2 Global Implantable Neurostimulation Devices Sales in Value by Region (2018-2023)

3.2.3 Global Implantable Neurostimulation Devices Sales (Volume & Value) Price and Gross Margin (2018-2023)

3.3 Global Implantable Neurostimulation Devices Forecasted Market Size by Region

3.3.1 Global Implantable Neurostimulation Devices Sales in Volume by Region (2024-2029)

3.3.2 Global Implantable Neurostimulation Devices Sales in Value by Region (2024-2029)

3.3.3 Global Implantable Neurostimulation Devices Sales (Volume & Value), Price and Gross Margin (2024-2029)

4 Global Implantable Neurostimulation Devices by Application

4.1 Implantable Neurostimulation Devices Market Segment by Application

4.1.1 Pain Management

4.1.2 Parkinson's Disease

4.1.3 Urinary and Fecal Incontinence

4.1.4 Epilepsy

4.1.5 Gastroparesis

4.1.6 Others

4.2 Global Implantable Neurostimulation Devices Market Size by Application

4.2.1 Global Implantable Neurostimulation Devices Market Size Overview by Application (2018-2029)

4.2.2 Global Implantable Neurostimulation Devices Historic Market Size Review by Application (2018-2023)

4.2.3 Global Implantable Neurostimulation Devices Forecasted Market Size by Application (2024-2029)

4.3 Key Regions Market Size Segment by Application

4.3.1 North America Implantable Neurostimulation Devices Sales Breakdown by Application (2018-2023)

4.3.2 Europe Implantable Neurostimulation Devices Sales Breakdown by Application (2018-2023)

4.3.3 Asia-Pacific Implantable Neurostimulation Devices Sales Breakdown by Application (2018-2023)

4.3.4 Latin America Implantable Neurostimulation Devices Sales Breakdown by Application (2018-2023)

4.3.5 Middle East and Africa Implantable Neurostimulation Devices Sales Breakdown by Application (2018-2023)

5 North America Implantable Neurostimulation Devices by Country

5.1 North America Implantable Neurostimulation Devices Historic Market Size by Country

5.1.1 North America Implantable Neurostimulation Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

5.1.2 North America Implantable Neurostimulation Devices Sales in Volume by Country (2018-2023)

5.1.3 North America Implantable Neurostimulation Devices Sales in Value by Country (2018-2023)

5.2 North America Implantable Neurostimulation Devices Forecasted Market Size by Country

5.2.1 North America Implantable Neurostimulation Devices Sales in Volume by Country (2024-2029)

5.2.2 North America Implantable Neurostimulation Devices Sales in Value by Country (2024-2029)

6 Europe Implantable Neurostimulation Devices by Country

6.1 Europe Implantable Neurostimulation Devices Historic Market Size by Country

6.1.1 Europe Implantable Neurostimulation Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

6.1.2 Europe Implantable Neurostimulation Devices Sales in Volume by Country (2018-2023)

6.1.3 Europe Implantable Neurostimulation Devices Sales in Value by Country (2018-2023)

6.2 Europe Implantable Neurostimulation Devices Forecasted Market Size by Country

6.2.1 Europe Implantable Neurostimulation Devices Sales in Volume by Country (2024-2029)

6.2.2 Europe Implantable Neurostimulation Devices Sales in Value by Country (2024-2029)

7 Asia-Pacific Implantable Neurostimulation Devices by Region

7.1 Asia-Pacific Implantable Neurostimulation Devices Historic Market Size by Region

7.1.1 Asia-Pacific Implantable Neurostimulation Devices Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029

7.1.2 Asia-Pacific Implantable Neurostimulation Devices Sales in Volume by Region (2018-2023)

7.1.3 Asia-Pacific Implantable Neurostimulation Devices Sales in Value by Region (2018-2023)

7.2 Asia-Pacific Implantable Neurostimulation Devices Forecasted Market Size by Region

7.2.1 Asia-Pacific Implantable Neurostimulation Devices Sales in Volume by Region (2024-2029)

7.2.2 Asia-Pacific Implantable Neurostimulation Devices Sales in Value by Region (2024-2029)

8 Latin America Implantable Neurostimulation Devices by Country

8.1 Latin America Implantable Neurostimulation Devices Historic Market Size by Country

8.1.1 Latin America Implantable Neurostimulation Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

8.1.2 Latin America Implantable Neurostimulation Devices Sales in Volume by Country (2018-2023)

8.1.3 Latin America Implantable Neurostimulation Devices Sales in Value by Country (2018-2023)

8.2 Latin America Implantable Neurostimulation Devices Forecasted Market Size by Country

8.2.1 Latin America Implantable Neurostimulation Devices Sales in Volume by Country (2024-2029)

8.2.2 Latin America Implantable Neurostimulation Devices Sales in Value by Country (2024-2029)

9 Middle East and Africa Implantable Neurostimulation Devices by Country

9.1 Middle East and Africa Implantable Neurostimulation Devices Historic Market Size by Country

9.1.1 Middle East and Africa Implantable Neurostimulation Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

9.1.2 Middle East and Africa Implantable Neurostimulation Devices Sales in Volume by Country (2018-2023)

9.1.3 Middle East and Africa Implantable Neurostimulation Devices Sales in Value by Country (2018-2023)

9.2 Middle East and Africa Implantable Neurostimulation Devices Forecasted Market Size by Country

9.2.1 Middle East and Africa Implantable Neurostimulation Devices Sales in Volume by Country (2024-2029)

9.2.2 Middle East and Africa Implantable Neurostimulation Devices Sales in Value by Country (2024-2029)

10 Company Profiles

10.1 Medtronic

10.1.1 Medtronic Company Information

10.1.2 Medtronic Introduction and Business Overview

10.1.3 Medtronic Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2018-2023)

10.1.4 Medtronic Implantable Neurostimulation Devices Products Offered

10.1.5 Medtronic Recent Development

10.2 Boston Scientific

10.2.1 Boston Scientific Company Information

10.2.2 Boston Scientific Introduction and Business Overview

10.2.3 Boston Scientific Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2018-2023)

10.2.4 Boston Scientific Implantable Neurostimulation Devices Products Offered

10.2.5 Boston Scientific Recent Development

10.3 St. Jude Medical (Abbott)

10.3.1 St. Jude Medical (Abbott) Company Information

10.3.2 St. Jude Medical (Abbott) Introduction and Business Overview

10.3.3 St. Jude Medical (Abbott) Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2018-2023)

10.3.4 St. Jude Medical (Abbott) Implantable Neurostimulation Devices Products Offered

10.3.5 St. Jude Medical (Abbott) Recent Development

10.4 LivaNova

10.4.1 LivaNova Company Information

10.4.2 LivaNova Introduction and Business Overview

10.4.3 LivaNova Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2018-2023)

10.4.4 LivaNova Implantable Neurostimulation Devices Products Offered

10.4.5 LivaNova Recent Development

10.5 Nevro

10.5.1 Nevro Company Information

10.5.2 Nevro Introduction and Business Overview

10.5.3 Nevro Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2018-2023)

10.5.4 Nevro Implantable Neurostimulation Devices Products Offered

10.5.5 Nevro Recent Development

10.6 NeuroPace

10.6.1 NeuroPace Company Information

10.6.2 NeuroPace Introduction and Business Overview

10.6.3 NeuroPace Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2018-2023)

10.6.4 NeuroPace Implantable Neurostimulation Devices Products Offered

10.6.5 NeuroPace Recent Development

10.7 Beijing Pins

10.7.1 Beijing Pins Company Information

10.7.2 Beijing Pins Introduction and Business Overview

10.7.3 Beijing Pins Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2018-2023)

10.7.4 Beijing Pins Implantable Neurostimulation Devices Products Offered

10.7.5 Beijing Pins Recent Development

10.8 Synapse Biomedical

10.8.1 Synapse Biomedical Company Information

10.8.2 Synapse Biomedical Introduction and Business Overview

10.8.3 Synapse Biomedical Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2018-2023)

10.8.4 Synapse Biomedical Implantable Neurostimulation Devices Products Offered

10.8.5 Synapse Biomedical Recent Development

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis

11.1 Implantable Neurostimulation Devices Key Raw Materials

11.1.1 Key Raw Materials

11.1.2 Key Raw Materials Price

11.1.3 Raw Materials Key Suppliers

11.2 Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Implantable Neurostimulation Devices Industrial Chain Analysis

11.4 Implantable Neurostimulation Devices Market Dynamics

11.4.1 Implantable Neurostimulation Devices Industry Trends

11.4.2 Implantable Neurostimulation Devices Market Drivers

11.4.3 Implantable Neurostimulation Devices Market Challenges

11.4.4 Implantable Neurostimulation Devices Market Restraints

12 Market Strategy Analysis, Distributors

12.1 Sales Channel

12.2 Implantable Neurostimulation Devices Distributors

12.3 Implantable Neurostimulation Devices Downstream Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.2 Data Source

14.2 Author Details

14.3 Disclaimer

FEATURED COMPANIES

St. Jude Medical (Abbott)

List of Tables

Table 1. Major Company of Spinal Cord Stimulation (SCS)

Table 2. Major Company of Gastric Electric Stimulation (GES)

Table 3. Major Company of Deep Brain Stimulation (DBS)

Table 4. Major Company of Sacral Nerve Stimulation (SNS)

Table 5. Major Company of Vagus Nerve Stimulation (VNS)

Table 6. Major Company of Others

Table 7. Global Implantable Neurostimulation Devices Sales by Type 2018 VS 2022 VS 2029 (US$ Million)

Table 8. Global Implantable Neurostimulation Devices Sales by Type (2018-2023) & (Units)

Table 9. Global Implantable Neurostimulation Devices Sales Market Share in Volume by Type (2018-2023)

Table 10. Global Implantable Neurostimulation Devices Sales by Type (2018-2023) & (US& Million)

Table 11. Global Implantable Neurostimulation Devices Market Share in Value by Type (2018-2023)

Table 12. Global Implantable Neurostimulation Devices Price by Type (2018-2023) & (K USD/Unit)

Table 13. Global Implantable Neurostimulation Devices Sales by Type (2024-2029) & (Units)

Table 14. Global Implantable Neurostimulation Devices Sales Market Share in Volume by Type (2024-2029)

Table 15. Global Implantable Neurostimulation Devices Sales by Type (2024-2029) & (US$ Million)

Table 16. Global Implantable Neurostimulation Devices Sales Market Share in Value by Type (2024-2029)

Table 17. Global Implantable Neurostimulation Devices Price by Type (2024-2029) & (K USD/Unit)

Table 18. North America Implantable Neurostimulation Devices Sales by Type (2018-2023) & (Units)

Table 19. North America Implantable Neurostimulation Devices Sales by Type (2018-2023) & (US$ Million)

Table 20. Europe Implantable Neurostimulation Devices Sales (Units) by Type (2018-2023)

Table 21. Europe Implantable Neurostimulation Devices Sales by Type (2018-2023) & (US$ Million)

Table 22. Asia-Pacific Implantable Neurostimulation Devices Sales (Units) by Type (2018-2023)

Table 23. Asia-Pacific Implantable Neurostimulation Devices Sales by Type (2018-2023) & (US$ Million)

Table 24. Latin America Implantable Neurostimulation Devices Sales (Units) by Type (2018-2023)

Table 25. Latin America Implantable Neurostimulation Devices Sales by Type (2018-2023) & (US$ Million)

Table 26. Middle East and Africa Implantable Neurostimulation Devices Sales (Units) by Type (2018-2023)

Table 27. Middle East and Africa Implantable Neurostimulation Devices Sales by Type (2018-2023) & (US$ Million)

Table 28. Global Implantable Neurostimulation Devices Sales by Company (2018-2023) & (Units)

Table 29. Global Implantable Neurostimulation Devices Sales Share by Company (2018-2023)

Table 30. Global Implantable Neurostimulation Devices Revenue by Company (2018-2023) & (US$ Million)

Table 31. Global Implantable Neurostimulation Devices Revenue Share by Company (2018-2023)

Table 32. Global Market Implantable Neurostimulation Devices Price by Company (2018-2023) & (K USD/Unit)

Table 33. Global Implantable Neurostimulation Devices Top Manufacturers Manufacturing Base Distribution and Sales Area

Table 34. Global Implantable Neurostimulation Devices Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 35. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Implantable Neurostimulation Devices as of 2022)

Table 36. Date of Key Manufacturers Enter into Implantable Neurostimulation Devices Market

Table 37. Key Manufacturers Implantable Neurostimulation Devices Product Type

Table 38. Mergers & Acquisitions, Expansion Plans

Table 39. Global Implantable Neurostimulation Devices Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029

Table 40. Global Implantable Neurostimulation Devices Sales by Region (2018-2023) & (Units)

Table 41. Global Implantable Neurostimulation Devices Sales Market Share in Volume by Region (2018-2023)

Table 42. Global Implantable Neurostimulation Devices Sales by Region (2018-2023) & (US$ Million)

Table 43. Global Implantable Neurostimulation Devices Sales Market Share in Value by Region (2018-2023)

Table 44. Global Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2018-2023)

Table 45. Global Implantable Neurostimulation Devices Sales by Region (2024-2029) & (Units)

Table 46. Global Implantable Neurostimulation Devices Sales Market Share in Volume by Region (2024-2029)

Table 47. Global Implantable Neurostimulation Devices Sales by Region (2024-2029) & (US$ Million)

Table 48. Global Implantable Neurostimulation Devices Sales Market Share in Value by Region (2024-2029)

Table 49. Global Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2024-2029)

Table 50. Global Implantable Neurostimulation Devices Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)

Table 51. Global Implantable Neurostimulation Devices Sales by Application (2018-2023) & (Units)

Table 52. Global Implantable Neurostimulation Devices Sales Market Share in Volume by Application (2018-2023)

Table 53. Global Implantable Neurostimulation Devices Sales by Application (2018-2023) & (US$ Million)

Table 54. Global Implantable Neurostimulation Devices Sales Market Share in Value by Application (2018-2023)

Table 55. Global Implantable Neurostimulation Devices Price by Application (2018-2023) & (K USD/Unit)

Table 56. Global Implantable Neurostimulation Devices Sales by Application (2024-2029) & (Units)

Table 57. Global Implantable Neurostimulation Devices Sales Market Share in Volume by Application (2024-2029)

Table 58. Global Implantable Neurostimulation Devices Sales by Application (2024-2029) & (US$ Million)

Table 59. Global Implantable Neurostimulation Devices Sales Market Share in Value by Application (2024-2029)

Table 60. Global Implantable Neurostimulation Devices Price by Application (2024-2029) & (K USD/Unit)

Table 61. North America Implantable Neurostimulation Devices Sales by Application (2018-2023) (Units)

Table 62. North America Implantable Neurostimulation Devices Sales by Application (2018-2023) & (US$ Million)

Table 63. Europe Implantable Neurostimulation Devices Sales by Application (2018-2023) (Units)

Table 64. Europe Implantable Neurostimulation Devices Sales by Application (2018-2023) & (US$ Million)

Table 65. Asia-Pacific Implantable Neurostimulation Devices Sales by Application (2018-2023) (Units)

Table 66. Asia-Pacific Implantable Neurostimulation Devices Sales by Application (2018-2023) & (US$ Million)

Table 67. Latin America Implantable Neurostimulation Devices Sales by Application (2018-2023) (Units)

Table 68. Latin America Implantable Neurostimulation Devices Sales by Application (2018-2023) & (US$ Million)

Table 69. Middle East and Africa Implantable Neurostimulation Devices Sales by Application (2018-2023) (Units)

Table 70. Middle East and Africa Implantable Neurostimulation Devices Sales by Application (2018-2023) & (US$ Million)

Table 71. North America Implantable Neurostimulation Devices Sales by Country (2018-2023) & (Units)

Table 72. North America Implantable Neurostimulation Devices Sales Market Share in Volume by Country (2018-2023)

Table 73. North America Implantable Neurostimulation Devices Sales by Country (2018-2023) & (US$ Million)

Table 74. North America Implantable Neurostimulation Devices Sales Market Share in Value by Country (2018-2023)

Table 75. North America Implantable Neurostimulation Devices Sales by Country (2024-2029) & (Units)

Table 76. North America Implantable Neurostimulation Devices Sales Market Share in Volume by Country (2024-2029)

Table 77. North America Implantable Neurostimulation Devices Sales by Country (2024-2029) & (US$ Million)

Table 78. North America Implantable Neurostimulation Devices Sales Market Share in Value by Country (2024-2029)

Table 79. Europe Implantable Neurostimulation Devices Sales by Country (2018-2023) & (Units)

Table 80. Europe Implantable Neurostimulation Devices Sales Market Share in Volume by Country (2018-2023)

Table 81. Europe Implantable Neurostimulation Devices Sales by Country (2018-2023) & (US$ Million)

Table 82. Europe Implantable Neurostimulation Devices Sales Market Share in Value by Country (2018-2023)

Table 83. Europe Implantable Neurostimulation Devices Sales by Country (2024-2029) & (Units)

Table 84. Europe Implantable Neurostimulation Devices Sales Market Share in Volume by Country (2024-2029)

Table 85. Europe Implantable Neurostimulation Devices Sales by Country (2024-2029) & (US$ Million)

Table 86. Europe Implantable Neurostimulation Devices Sales Market Share in Value by Country (2024-2029)

Table 87. Asia-Pacific Implantable Neurostimulation Devices Sales by Region (2018-2023) & (Units)

Table 88. Asia-Pacific Implantable Neurostimulation Devices Sales Market Share in Volume by Region (2018-2023)

Table 89. Asia-Pacific Implantable Neurostimulation Devices Sales by Region (2018-2023) & (US$ Million)

Table 90. Asia-Pacific Implantable Neurostimulation Devices Sales Market Share in Value by Region (2018-2023)

Table 91. Asia-Pacific Implantable Neurostimulation Devices Sales by Region (2024-2029) & (Units)

Table 92. Asia-Pacific Implantable Neurostimulation Devices Sales Market Share in Volume by Region (2024-2029)

Table 93. Asia-Pacific Implantable Neurostimulation Devices Sales by Region (2024-2029) & (US$ Million)

Table 94. Asia-Pacific Implantable Neurostimulation Devices Sales Market Share in Value by Region (2024-2029)

Table 95. Latin America Implantable Neurostimulation Devices Sales by Country (2018-2023) & (Units)

Table 96. Latin America Implantable Neurostimulation Devices Sales Market Share in Volume by Country (2018-2023)

Table 97. Latin America Implantable Neurostimulation Devices Sales by Country (2018-2023) & (US$ Million)

Table 98. Latin America Implantable Neurostimulation Devices Sales Market Share in Value by Country (2018-2023)

Table 99. Latin America Implantable Neurostimulation Devices Sales by Country (2024-2029) & (Units)

Table 100. Latin America Implantable Neurostimulation Devices Sales Market Share in Volume by Country (2024-2029)

Table 101. Latin America Implantable Neurostimulation Devices Sales by Country (2024-2029) & (US$ Million)

Table 102. Latin America Implantable Neurostimulation Devices Sales Market Share in Value by Country (2024-2029)

Table 103. Middle East and Africa Implantable Neurostimulation Devices Sales by Country (2018-2023) & (Units)

Table 104. Middle East and Africa Implantable Neurostimulation Devices Sales Market Share in Volume by Country (2018-2023)

Table 105. Middle East and Africa Implantable Neurostimulation Devices Sales by Country (2018-2023) & (US$ Million)

Table 106. Middle East and Africa Implantable Neurostimulation Devices Sales Market Share in Value by Country (2018-2023)

Table 107. Middle East and Africa Implantable Neurostimulation Devices Sales by Country (2024-2029) & (Units)

Table 108. Middle East and Africa Implantable Neurostimulation Devices Sales Market Share in Volume by Country (2024-2029)

Table 109. Middle East and Africa Implantable Neurostimulation Devices Sales by Country (2024-2029) & (US$ Million)

Table 110. Middle East and Africa Implantable Neurostimulation Devices Sales Market Share in Value by Country (2024-2029)

Table 111. Medtronic Company Information

Table 112. Medtronic Introduction and Business Overview

Table 113. Medtronic Implantable Neurostimulation Devices Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2018-2023)

Table 114. Medtronic Implantable Neurostimulation Devices Product

Table 115. Medtronic Recent Development

Table 116. Boston Scientific Company Information

Table 117. Boston Scientific Introduction and Business Overview

Table 118. Boston Scientific Implantable Neurostimulation Devices Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2018-2023)

Table 119. Boston Scientific Implantable Neurostimulation Devices Product

Table 120. Boston Scientific Recent Development

Table 121. St. Jude Medical (Abbott) Company Information

Table 122. St. Jude Medical (Abbott) Introduction and Business Overview

Table 123. St. Jude Medical (Abbott) Implantable Neurostimulation Devices Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2018-2023)

Table 124. St. Jude Medical (Abbott) Implantable Neurostimulation Devices Product

Table 125. St. Jude Medical (Abbott) Recent Development

Table 126. LivaNova Company Information

Table 127. LivaNova Introduction and Business Overview

Table 128. LivaNova Implantable Neurostimulation Devices Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2018-2023)

Table 129. LivaNova Implantable Neurostimulation Devices Product

Table 130. LivaNova Recent Development

Table 131. Nevro Company Information

Table 132. Nevro Introduction and Business Overview

Table 133. Nevro Implantable Neurostimulation Devices Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2018-2023)

Table 134. Nevro Implantable Neurostimulation Devices Product

Table 135. Nevro Recent Development

Table 136. NeuroPace Company Information

Table 137. NeuroPace Introduction and Business Overview

Table 138. NeuroPace Implantable Neurostimulation Devices Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2018-2023)

Table 139. NeuroPace Implantable Neurostimulation Devices Product

Table 140. NeuroPace Recent Development

Table 141. Beijing Pins Company Information

Table 142. Beijing Pins Introduction and Business Overview

Table 143. Beijing Pins Implantable Neurostimulation Devices Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2018-2023)

Table 144. Beijing Pins Implantable Neurostimulation Devices Product

Table 145. Beijing Pins Recent Development

Table 146. Synapse Biomedical Company Information

Table 147. Synapse Biomedical Introduction and Business Overview

Table 148. Synapse Biomedical Implantable Neurostimulation Devices Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2018-2023)

Table 149. Synapse Biomedical Implantable Neurostimulation Devices Product

Table 150. Synapse Biomedical Recent Development

Table 151. Key Raw Materials Lists

Table 152. Raw Materials Key Suppliers Lists

Table 153. Implantable Neurostimulation Devices Market Trends

Table 154. Implantable Neurostimulation Devices Market Drivers

Table 155. Implantable Neurostimulation Devices Market Challenges

Table 156. Implantable Neurostimulation Devices Market Restraints

Table 157. Implantable Neurostimulation Devices Distributors List

Table 158. Implantable Neurostimulation Devices Downstream Customers

Table 159. Research Programs/Design for This Report

Table 160. Key Data Information from Secondary Sources

Table 161. Key Data Information from Primary Sources

List of Figures

Figure 1. Implantable Neurostimulation Devices Product Picture

Figure 2. Global Implantable Neurostimulation Devices Market Size, 2018 VS 2022 VS 2029 (US$ Million)

Figure 3. Global Implantable Neurostimulation Devices Market Size Status and Outlook (2018-2029) & (US$ Million)

Figure 4. Global Implantable Neurostimulation Devices Sales Status and Outlook (2018-2029) & (Units)

Figure 5. Product Picture of Spinal Cord Stimulation (SCS)

Figure 6. Global Spinal Cord Stimulation (SCS) Sales YoY Growth (2018-2029) & (Units)

Figure 7. Product Picture of Gastric Electric Stimulation (GES)

Figure 8. Global Gastric Electric Stimulation (GES) Sales YoY Growth (2018-2029) & (Units)

Figure 9. Product Picture of Deep Brain Stimulation (DBS)

Figure 10. Global Deep Brain Stimulation (DBS) Sales YoY Growth (2018-2029) & (Units)

Figure 11. Product Picture of Sacral Nerve Stimulation (SNS)

Figure 12. Global Sacral Nerve Stimulation (SNS) Sales YoY Growth (2018-2029) & (Units)

Figure 13. Product Picture of Vagus Nerve Stimulation (VNS)

Figure 14. Global Vagus Nerve Stimulation (VNS) Sales YoY Growth (2018-2029) & (Units)

Figure 15. Product Picture of Others

Figure 16. Global Others Sales YoY Growth (2018-2029) & (Units)

Figure 17. Global Implantable Neurostimulation Devices Sales by Type (2018-2029) & (US$ Million)

Figure 18. Global Implantable Neurostimulation Devices Sales Market Share by Type in 2022 & 2029

Figure 19. North America Implantable Neurostimulation Devices Sales Market Share in Volume by Type in 2022

Figure 20. North America Implantable Neurostimulation Devices Sales Market Share in Value by Type in 2022

Figure 21. Europe Implantable Neurostimulation Devices Sales Market Share in Volume by Type in 2022

Figure 22. Europe Implantable Neurostimulation Devices Sales Market Share in Value by Type in 2022

Figure 23. Asia-Pacific Implantable Neurostimulation Devices Sales Market Share in Volume by Type in 2022

Figure 24. Asia-Pacific Implantable Neurostimulation Devices Sales Market Share in Value by Type in 2022

Figure 25. Latin America Implantable Neurostimulation Devices Sales Market Share in Volume by Type in 2022

Figure 26. Latin America Implantable Neurostimulation Devices Sales Market Share in Value by Type in 2022

Figure 27. Middle East and Africa Implantable Neurostimulation Devices Sales Market Share in Volume by Type in 2022

Figure 28. Middle East and Africa Implantable Neurostimulation Devices Sales Market Share in Value by Type in 2022

Figure 29. The 5 and 10 Largest Manufacturers in the World: Market Share by Implantable Neurostimulation Devices Sales in 2022

Figure 30. The 5 and 10 Largest Manufacturers in the World: Market Share by Implantable Neurostimulation Devices Revenue in 2022

Figure 31. Implantable Neurostimulation Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022

Figure 32. Product Picture of Pain Management

Figure 33. Global Pain Management Sales YoY Growth (2018-2029) & (Units)

Figure 34. Product Picture of Parkinson's Disease

Figure 35. Global Parkinson's Disease Sales YoY Growth (2018-2029) & (Units)

Figure 36. Product Picture of Urinary and Fecal Incontinence

Figure 37. Global Urinary and Fecal Incontinence Sales YoY Growth (2018-2029) & (Units)

Figure 38. Product Picture of Epilepsy

Figure 39. Global Epilepsy Sales YoY Growth (2018-2029) & (Units)

Figure 40. Product Picture of Gastroparesis

Figure 41. Global Gastroparesis Sales YoY Growth (2018-2029) & (Units)

Figure 42. Product Picture of Others

Figure 43. Global Others Sales YoY Growth (2018-2029) & (Units)

Figure 44. Global Implantable Neurostimulation Devices Sales by Application (2018-2029) & (US$ Million)

Figure 45. Global Implantable Neurostimulation Devices Sales Market Share by Application in 2022 & 2029

Figure 46. North America Implantable Neurostimulation Devices Sales Market Share in Volume by Application in 2022

Figure 47. North America Implantable Neurostimulation Devices Sales Market Share in Value by Application in 2022

Figure 48. Europe Implantable Neurostimulation Devices Sales Market Share in Volume by Application in 2022

Figure 49. Europe Implantable Neurostimulation Devices Sales Market Share in Value by Application in 2022

Figure 50. Asia-Pacific Implantable Neurostimulation Devices Sales Market Share in Volume by Application in 2022

Figure 51. Asia-Pacific Implantable Neurostimulation Devices Sales Market Share in Value by Application in 2022

Figure 52. Latin America Implantable Neurostimulation Devices Sales Market Share in Volume by Application in 2022

Figure 53. Latin America Implantable Neurostimulation Devices Sales Market Share in Value by Application in 2022

Figure 54. Middle East and Africa Implantable Neurostimulation Devices Sales Market Share in Value by Application in 2022

Figure 55. Key Raw Materials Price

Figure 56. Implantable Neurostimulation Devices Manufacturing Cost Structure

Figure 57. Implantable Neurostimulation Devices Industrial Chain Analysis

Figure 58. Channels of Distribution

Figure 59. Distributors Profiles

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions